The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Targeted Venetoclax Therapy in t(11;14) Multiple Myeloma: Real World Data From Seven Hungarian Centers
|
|---|---|
| Published in |
Pathology & Oncology Research, February 2022
|
| DOI | 10.3389/pore.2022.1610276 |
| Pubmed ID | |
| Authors |
Virág Réka Szita, Gábor Mikala, András Kozma, János Fábián, Apor Hardi, Hussain Alizadeh, Péter Rajnics, László Rejtő, Tamás Szendrei, László Váróczy, Zsolt Nagy, Árpád Illés, István Vályi-Nagy, Tamás Masszi, Gergely Varga |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 33% |
| Unknown | 2 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 67% |
| Scientists | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 30 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Unspecified | 8 | 27% |
| Researcher | 2 | 7% |
| Other | 2 | 7% |
| Student > Master | 2 | 7% |
| Librarian | 1 | 3% |
| Other | 1 | 3% |
| Unknown | 14 | 47% |
| Readers by discipline | Count | As % |
|---|---|---|
| Unspecified | 8 | 27% |
| Medicine and Dentistry | 3 | 10% |
| Biochemistry, Genetics and Molecular Biology | 2 | 7% |
| Arts and Humanities | 1 | 3% |
| Unknown | 16 | 53% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 October 2022.
All research outputs
#16,734,944
of 25,392,582 outputs
Outputs from Pathology & Oncology Research
#321
of 780 outputs
Outputs of similar age
#254,867
of 450,103 outputs
Outputs of similar age from Pathology & Oncology Research
#7
of 14 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 780 research outputs from this source. They receive a mean Attention Score of 2.1. This one has gotten more attention than average, scoring higher than 56% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 450,103 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 39th percentile – i.e., 39% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.